Creyon Bio

Curated by Signal

Provider of drug design and oligonucleotide-based drug development platform

Overview

Provider of drug design and oligonucleotide-based drug development platform. The company uses proprietary machine-learning and AI models to design oligonucleotide-based medicines, for treating rare or common diseases.

Key facts

Founded: 2019
Headquarters: San Diego, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Helix
Provider of a genomic database for clinical research
Life Sciences TechnologySan Francisco, United States
Premama Wellness
Powdered supplements to support postnatal nutritional needs
Life Sciences TechnologyProvidence, United States
EXA Biosciences
Developer of next generation of therapeutic biologics
Life Sciences TechnologyBoston, United States

About Creyon Bio

What does Creyon Bio do?

Provider of drug design and oligonucleotide-based drug development platform.

Where is Creyon Bio headquartered?

Creyon Bio is headquartered in San Diego, United States.

When was Creyon Bio founded?

Creyon Bio was founded in 2019.

Which sector is Creyon Bio in?

Creyon Bio operates in Life Sciences Technology.

Who are Creyon Bio's competitors?

Companies similar to Creyon Bio include Helix, Premama Wellness, and EXA Biosciences.